Skip to main navigationSkip to main content
The University of Southampton
Clinical Ethics and Law at Southampton

"Rapid technological advances promise big improvements in medical care. The world needs leadership in understanding and responding to the ethical and societal impact of these radical changes. CELS brings together interdisciplinary expertise to meet this need by addressing the ethical, legal and societal issues through research, education, policy engagement and public dialogue".

The latest Joint Committee guidelines on Consent and confidentiality in genomic medicine released

July 2019: This edition was written by Anneke Lucassen (Professor and honorary consultant in clinical genetics, Faculty of Medicine, University of Southampton and Wessex Clinical Genetics Service, University Hospitals Southampton, UK; and chair of the British Society for Genetic Medicine) and Alison Hall (head of humanities, PHG Foundation, Cambridge, UK; and chair of the Ethics and Policy Committee of the British Society for Genetic Medicine).

Difficult Decisions in Paediatrics Day - 11th October 2019

Exploring ethical issues and clinical decision-making for children with life-limiting illnesses. There is an appetite for a forum through which joined-up working in Wessex could be facilitated, where multidisciplinary discussions could be held and where the difficult ethical issues raised could begin to be discussed. This day aims to explore some of the most challenging discussions that need to be had in paediatrics and discuss if and how a regional paediatric Clinical Ethics Committee might help future cases.

Dr Anneke Lucassen presented at the 'Genomics Summit' in Parliament advocating for greater context-oriented genomic approach related to genetic disease

'Genomics Summit’ held in Parliament on 31 October 2018, organised jointly by the House of Commons Science & Technology Committee and the Department of Health and Social Care. The event followed on from the Committee’s Report on ‘genomics and genome-editing in the NHS’, the Government’s response to the Committee Report, and the launch of the Genomic Medicine Service in NHS England

EPPiGen’s response to NHS Long Term Plan

The NHS Long-Term plan was published recently, and we were delighted to see the prominence given to genomics. The plan details ambitions for the NHS to become ‘the first national health care system to offer whole genome sequencing as part of routine care’. The immediate focus of this will be on children with cancer, all of whom will receive whole genome sequencing ‘to enable more comprehensive and precise diagnosis, and access to more personalised treatments’. We are pleased that this commitment will help to keep the UK at the forefront of clinical genomics, and our national health service, provides a great vehicle for large scale introduction of these innovative technologies into clinical practice.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×